These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22701324)

  • 1. Role of aripiprazole in treatment-resistant schizophrenia.
    Mossaheb N; Kaufmann RM
    Neuropsychiatr Dis Treat; 2012; 8():235-44. PubMed ID: 22701324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.
    Mossaheb N; Spindelegger C; Asenbaum S; Fischer P; Barnas C
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):502-5. PubMed ID: 20218805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.
    Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
    JAMA Psychiatry; 2019 May; 76(5):499-507. PubMed ID: 30785608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Di Nardo F; Santoro V; Spina E; Zoccali RA
    Schizophr Res; 2011 Apr; 127(1-3):93-9. PubMed ID: 21262565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.
    Ziegenbein M; Wittmann G; Kropp S
    Clin Drug Investig; 2006; 26(3):117-24. PubMed ID: 17163242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?
    Vasiliu O
    Front Psychiatry; 2022; 13():1069432. PubMed ID: 36523870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
    Karunakaran K; Tungaraza TE; Harborne GC
    J Psychopharmacol; 2007 Jun; 21(4):453-6. PubMed ID: 17050662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One Plus One Sometimes Equals More Than Two: Long-acting Injectable Aripiprazole Adjunction in Clozapine-Resistant Schizophrenia.
    Balcioglu YH; Gokcay H; Yesilkaya UH
    Clin Neuropharmacol; 2020; 43(5):166-168. PubMed ID: 32947430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.
    Nosè M; Accordini S; Artioli P; Barale F; Barbui C; Beneduce R; Berardi D; Bertolazzi G; Biancosino B; Bisogno A; Bivi R; Bogetto F; Boso M; Bozzani A; Bucolo P; Casale M; Cascone L; Ciammella L; Cicolini A; Cipresso G; Cipriani A; Colombo P; Dal Santo B; De Francesco M; Di Lorenzo G; Di Munzio W; Ducci G; Erlicher A; Esposito E; Ferrannini L; Ferrato F; Ferro A; Fragomeno N; Parise VF; Frova M; Gardellin F; Garzotto N; Giambartolomei A; Giupponi G; Grassi L; Grazian N; Grecu L; Guerrini G; Laddomada F; Lazzarin E; Lintas C; Malchiodi F; Malvini L; Marchiaro L; Marsilio A; Mauri MC; Mautone A; Menchetti M; Migliorini G; Mollica M; Moretti D; Mulè S; Nicholau S; Nosè F; Occhionero G; Pacilli AM; Pecchioli S; Percudani M; Piantato E; Piazza C; Pontarollo F; Pycha R; Quartesan R; Rillosi L; Risso F; Rizzo R; Rocca P; Roma S; Rossattini M; Rossi G; Rossi G; Sala A; Santilli C; Saraò G; Sarnicola A; Sartore F; Scarone S; Sciarma T; Siracusano A; Strizzolo S; Tansella M; Targa G; Tasser A; Tomasi R; Travaglini R; Veronese A; Ziero S
    Trials; 2009 May; 10():31. PubMed ID: 19445659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.
    Li X; Guo X; Fan X; Feng T; Wang C; Yao Z; Xu X; Chen Z; Wang H; Xie S; He J; Zhuo K; Xiang Q; Cen H; Wang J; Smith RC; Jin H; Keshavan MS; Marder SR; Davis JM; Jiang K; Xu Y; Liu D
    Schizophr Res; 2021 Apr; 230():87-94. PubMed ID: 33279374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: a systematic review and meta-analysis of randomized-controlled trials.
    Srisurapanont M; Suttajit S; Maneeton N; Maneeton B
    J Psychiatr Res; 2015 Mar; 62():38-47. PubMed ID: 25619176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case of Resistant Schizophrenia Successfully Treated With Clozapine/Long-acting Injectable Aripiprazole Combination.
    Sepede G; Di Iorio G; Spano MC; Lorusso M; Sarchione F; Santacroce R; Salerno RM; Di Giannantonio M
    Clin Neuropharmacol; 2016; 39(6):322-324. PubMed ID: 27764052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia.
    De Risio A; Pancheri A; Simonetti G; Giannarelli D; Stefanutto L; Gentile B
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1112-6. PubMed ID: 21447367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
    Cipriani A; Accordini S; Nosè M; Purgato M; Girlanda F; Tansella M; Barbui C
    J Clin Psychopharmacol; 2013 Aug; 33(4):533-7. PubMed ID: 23775051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.